Background
==========

In the past, black veterans hospitalized with acute myocardial infarction (AMI) were less likely to undergo cardiac revascularization procedures, including percutaneous coronary intervention (PCI), than their white counterparts \[[@B1]-[@B7]\]. These differences in the use of cardiac revascularization procedures were observed over 10 years ago in a health care system where there was and still is equal access to care. It is uncertain whether these differences in the use of PCI persist in the era of drug eluting stents. It is possible that black patients are less likely to be the beneficiaries of new technology due to receiving care at hospitals with lower procedure rates and greater disparity in racial composition \[[@B8]\]. On the other hand, the indications for PCI in the setting of AMI have expanded significantly due to new technology, and it is possible that this trend has affected the proportions of black patients undergoing PCI. The purpose of this study is to determine if in the era of drug eluting stents, black veterans with AMI are less likely to receive PCI than their white counterparts.

Methods
=======

Patient population
------------------

Between July 20, 2003 and August 19, 2004, there were 6262 veterans who were admitted to Veterans Health Administration (VHA) medical centers and developed AMI that was documented by standard electrocardiographic, troponin, and/or other clinical evidence. Not included in this count were patients who were transferred into VHA hospitals from other medical facilities, because important baseline information was not available. Also excluded were patients who had AMI while hospitalized for another medical condition.

Information for this study was collected as part of the VHA External Peer Review Program for quality monitoring and improvement for a variety of medical conditions and procedures, including AMI. Patients with International Classification of Diseases 9^th^Revision diagnosis codes 410.xx were identified from administrative data housed at the Austin Automation Center. Working with the peer review abstraction contractor, West Virginia Medical Institute, the VHA Office of Quality and Performance generated a list of patients that was transmitted to VHA facilities where both paper and electronic medical records were manually abstracted by trained abstractors using standard reporting forms. Abstracted data were then entered into a database maintained by the contractor.

Study variables
---------------

We used information from the peer review database and Department of Veterans Affairs workload files to describe demographics and personal characteristics, vital status and cardiac procedure use after hospital discharge \[[@B9]\]. Race/ethnicity was obtained from the medical inpatient datasets and outpatient care files at Austin and was classified as 1) Hispanic, 2) Black, 3) White, 4) Other, or 5) Unknown.

Medical centers were classified according to type of invasive cardiac procedures offered: 1) no cardiac catheterization, 2) cardiac catheterization only, 3) PCI, or 4) full range of procedures including coronary artery bypass graft surgery. Clinical information such as cardiac medications, time from symptom onset to hospital admission, initial heart rate, systolic and diastolic blood pressures, and initial symptoms were obtained from the medical record. The initial electrocardiographic diagnosis of ST elevation myocardial infarction included those with ST elevation ≥ 1 millivolt in 2 or more contiguous leads and/or left bundle branch block. The remainder of patients had non-ST elevation AMI. Both the initial and highest troponin values were recorded; positive tests were determined according to criteria for the particular type of assay used. In both groups, over 99% of AMIs were confirmed by troponin elevations.

Cardiac treatments and procedures were recorded as part of chart abstraction, but workload data from the Austin Automation Center were also accessed to determine cardiac procedure use after discharge. For patients who presented to the hospital with ST segment elevation, PCI within 12 hours of admission was defined. In addition, 30-day rates of cardiac catheterization, PCI, and coronary artery bypass surgery were constructed.

Statistical methods
-------------------

Comparisons between black and white patients were made with the Chi-square test for categorical variables and the 2 sample t-test for continuous measures. Logistic regression was used to further examine the association between race and the use of PCI performed ≤ 30 days after admission. We used backward stepwise logistic regression to select predictors of PCI use. After statistically significant predictors were selected from candidate variables in tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, the black/white variable was forced in to determine its association with PCI use. Analyses were run with and without a cluster correction for medical center.

Ethics and consent
------------------

This study was approved for expedited review by the University of Washington Institutional Review Board and was granted a waiver of informed consent.

Results
=======

From the 6262 individuals in this study, only black (n = 680) or white (n = 3529) patients were included, resulting in 4209 individuals. Excluded were those of other racial or ethnic groups (n = 388) or those whose race was unknown (n = 1665). Race/ethnicity was unknown for over 25% of individuals. Compared to their white counterparts, black individuals, who comprised 16% of the study group, were younger, less often had lipid disorders, previous coronary artery bypass graft surgery, or chronic obstructive pulmonary disease but more often had diabetes, renal disease, or dementia (table [1](#T1){ref-type="table"}). In addition, black patients lived closer to VHA medical centers and more often resided in the South region of the United States. Significantly, a higher proportion of black veterans smoked in the past year. The distribution of cardiac medications used prior to admission was similar in the 2 groups.

With respect to presenting signs and symptoms, black and white veterans were similar, except that the former group had higher systolic and diastolic blood pressures on admission (table [2](#T2){ref-type="table"}). Symptoms were similar in the 2 groups, although black individuals reported less shoulder pain. ST segment elevation on the initial electrocardiogram was present in 16% and 18% (p = 0.10) of black and white patients, respectively, although the first troponin assay was more often elevated in black veterans (76% vs. 69%, p = 0.001). The highest troponin reading was elevated in 99% of both groups.

There were distinct differences concerning the type of admitting hospital as well as the kind of cardiology services received. Almost 75% of black patients were admitted to VHA medical centers with capacity to perform PCI, compared to only 54% of white veterans. Significantly, 29% of white veterans were admitted to VHA hospitals without cardiac catheterization laboratories. Consistent with this result was the finding that white individuals were more likely to be transferred for PCI than were black patients (table [3](#T3){ref-type="table"}). With respect to cardiology services, over 90% of veterans received them, although 49% of black individuals had a cardiology attending as compared to 38% of white veterans (p \< 0.0001).

Rates of cardiac catheterization performed ≤ 30 days after admission were similar in the 2 groups as were rates of PCI performed ≤ 12 hours from admission (table [3](#T3){ref-type="table"}). However, a significantly lower proportion of black veterans received PCI ≤ 30 days after admission (odds ratio = 0.71, 95% confidence interval = 0.60--0.85). Even among those who underwent cardiac catheterization, the rate of PCI was still lower in black veterans (48% vs. 59%, p \< 0.0001). After adjusting for history of cerebrovascular disease, renal disease, chronic obstructive pulmonary disease, dementia, chest pain on admission, ST elevation on the admission electrocardiogram, prolonged chest pain, age, geographic region, and availability of PCI services at the admitting hospital, black patients had a 21% lower likelihood of undergoing PCI (odds ratio = 0.79, 95% confidence interval = 0.71--0.88). The confidence intervals were adjusted for the clustering of patients within medical centers and were not appreciably different from the unadjusted ones. The model had adequate discrimination and calibration as indicated by the area under the receiver operating characteristic curve (c statistic = 0.75, 95% confidence interval = 0.73--0.76) and statistically non-significant Hosmer-Lemeshow test (p = 0.50).

Discussion
==========

For many years, race and gender differences in the use of cardiac revascularization procedures have been noted, and it appears that they have persisted through time \[[@B10]\]. Similar differences have been noted in VHA, although gender differences are less relevant given that relatively few women with AMI are treated in VHA medical centers \[[@B1]-[@B7]\]. In the current study, a higher proportion of black veterans were younger, had diabetes mellitus, renal disease, dementia, or elevated blood pressure, although more white patients had lipid disorders, previous coronary artery bypass surgery, or chronic obstructive pulmonary disease. Significantly, a higher proportion of black individuals smoked cigarettes in the year prior to admission.

Even though they were more likely to be admitted to medical centers with interventional capability, black veterans were less likely to undergo PCI. This was true in both unadjusted and adjusted analyses. White patients were 2 times more likely to be transferred for PCI, and this increased the numbers undergoing PCI. Equal proportions of African-Americans underwent emergent or urgent PCI, and although white veterans more often underwent bypass surgery, the absolute difference was slightly less than 4%.

In this study there were no black-white differences regarding the use of cardiac catheterization, although this was not the case in a previous study conducted in VHA medical centers \[[@B11]\]. The fact that there were no black-white differences with respect to use of cardiac catheterization may provide a possible explanation for the observed difference with respect to PCI. If results of cardiac catheterization indicated that black veterans had minimal coronary artery disease or had lesions that were not amenable to intervention, then the difference could be explained. Unfortunately, measures of extent of coronary disease were not collected as part of the records abstraction. Peniston et al. compared the use of cardiac revascularization procedures in African-American and white veterans who underwent cardiac catheterization, and did not find racial differences after adjusting for extent of disease \[[@B7]\]. Whittle et al. reported that among clinically similar black and white veterans undergoing coronary angiography, black patients were less likely to have obstructive coronary disease \[[@B12]\].

In addition to the absence of catheterization results, another limitation of this study was that an undetermined number of veterans may have received PCI in non VHA hospitals. With the exception of Medicare data (which were not available for this study), these procedures are not recorded in national databases, and therefore could not be identified. If a higher proportion of white patients underwent PCI in non VHA hospitals, then the racial difference reported in this study may have been underestimated.

Over 25% of veterans were of unknown race. Recently the means for acquisition of race/ethnicity have changed in VHA. Race/ethnicity is now reported by the patient rather than determined by the individual provider or administrative assistant responsible for entering data into the electronic medical record. If the question is not asked or if the patient is not present when data are entered, then race/ethnicity is unknown.

Among those with unknown race, 43% had PCI within 30 days of admission; these individuals were on average 66 years of age and were less likely to have chronic conditions such as diabetes, congestive heart failure, lung disease, or cerebrovascular disease. Therefore patients with unknown race were relatively healthier and underwent PCI more often than their counterparts with known race. The problem of unknown race in VHA has been more apparent in the past several years. Therefore, for younger patients who did not use VHA health care in the 5 to 10 years prior to their events, race information from that time was not available to fill in missing information for 2003--2004. We were reluctant to impute race given the lack of adequate measures of characteristics highly correlated with race, such as income and education.

Conclusion
==========

In this era of drug eluting stents and more aggressive treatment for AMI, black-white differences in the use of PCI persist even in the VHA, where access to procedures is not based on the ability to pay. However, given the equivalent use of cardiac catheterization as well as the equivalent use of PCI within 12 hours of admission, it is possible that less extensive or minimal coronary artery disease in black veterans could explain the observed difference.
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Figures and Tables
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###### 

Baseline demographics, medical histories, and prior cardiac medications by race

  **Variable**                                **Black (n = 680)**   **White (n = 3529)**   **P-value**
  ------------------------------------------- --------------------- ---------------------- -------------
  Mean age (years)                            67 ± 13               70 ± 11                \<0.0001
  Age                                                                                      \<0.0001
   \< 50                                      9%                    3%                     
   50--59                                     27%                   18%                    
   60--64                                     9%                    11%                    
   65--69                                     8%                    11%                    
   70--79                                     26%                   32%                    
   80--89                                     18%                   22%                    
   90+                                        2%                    2%                     
  Men                                         99%                   98%                    0.08
  Body mass index                             27.0 ± 6.0            28.0 ± 6.0             \<0.0001
  Miles from home to hospital                 22 ± 88               41 ± 116               \<0.0001
  Geographic region of medical center                                                      \<0.0001
   Northeast                                  16%                   15%                    
   South                                      52%                   43%                    
   Midwest                                    21%                   21%                    
   West                                       11%                   20%                    
  *Medical histories*                                                                      
   Myocardial infarction                      25%                   28%                    0.14
   Lipid disorder                             55%                   64%                    \<0.0001
   Coronary angioplasty                       12%                   14%                    0.14
   Coronary artery bypass surgery             10%                   24%                    \<0.0001
   Congestive heart failure                   33%                   31%                    0.43
   Diabetes mellitus                          28%                   23%                    0.004
   Renal disease                              18%                   13%                    \<0.0001
   Cerebrovascular disease                    9%                    8%                     0.46
   Chronic obstructive pulmonary disease      13%                   23%                    \<0.0001
   Dementia                                   19%                   15%                    0.016
   Cancer                                     10%                   10%                    0.81
   Cigarette smoking in past year             41%                   31%                    \<0.0001
  *Previous medications*                                                                   
   Aspirin                                    48%                   49%                    0.52
   Beta blockers                              51%                   54%                    0.13
   Angiotensin converting enzyme inhibitors   50%                   47%                    0.24
   Lipid lowering agents                      48%                   53%                    0.031
   Insulin                                    13%                   14%                    0.61
   Platelet inhibitors                        11%                   12%                    0.20

AMI Acute myocardial infarction

###### 

Presenting signs and symptoms

  **Variable**                                    **Black (n = 680)**   **White (n = 3529)**   **P-value**
  ----------------------------------------------- --------------------- ---------------------- -------------
  Time from symptom onset to hospital admission                                                
   ≤ 1 hour                                       5%                    6%                     0.12
   1--2 hours                                     9%                    10%                    
   2--6 hours                                     20%                   24%                    
   6--12 hours                                    13%                   13%                    
   12--24 hours                                   17%                   13%                    
   \> 24 hours                                    36%                   34%                    
  Heart rate                                      87 ± 25               87 ± 23                0.75
  Systolic blood pressure                         143 ± 33              138 ± 31               \<0.0001
  Diastolic blood pressure                        80 ± 20               75 ± 19                \<0.0001
  Symptoms                                                                                     
   Chest pain                                     56%                   58%                    0.39
   Pressure                                       17%                   18%                    0.58
   Belching                                       6%                    4%                     0.23
   Shoulder pain                                  21%                   30%                    \<0.0001
   Nausea                                         22%                   18%                    0.031
   Diaphoresis                                    14%                   17%                    0.09
   Dyspnea                                        45%                   43%                    0.36

###### 

Treatments, transfer status, in-hospital events, and mortality

  ***Variable***                                                        ***Black (n = 680)***   ***White (n = 3529)***   ***P-value***
  --------------------------------------------------------------------- ----------------------- ------------------------ ---------------
  Cardiac catheterization ≤ 30 days from admission                      59%                     57%                      0.52
  Percutaneous coronary intervention ≤ 12 hours from admission          8%                      8%                       0.80
  Percutaneous coronary intervention ≤ 30 days from admission           32%                     40%                      \<0.0001
  Drug eluting stent                                                    7%                      10%                      0.024
  Transfer to another hospital for percutaneous coronary intervention   8%                      15%                      \<0.0001
  Coronary artery bypass graft surgery ≤ 30 days from admission         5%                      8%                       0.001

AMI Acute myocardial infarction
